IGM Biosciences(IGMS) - 2024 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2025 IGM Biosciences, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39045 77-0349194 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 325 E. Middlefield Road Mountain View, California 94043 (Address of Principal Executive Of ...